Real‐world study on <scp>HBsAg</scp> loss of combination therapy in <scp>HBeAg</scp> ‐negative chronic hepatitis B patients-Reference-Cited by-全球学者库

Real‐world study on HBsAg loss of combination therapy in HBeAg ‐negative chronic hepatitis B patients

Published:2022-07-06 Issue:9 Volume:29 Page:765-776
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Chu Jun‐Hao¹^ORCID,Huang Yan²,Xie Dong‐Ying¹³⁴,Deng Hong¹³⁴,Wei Jia⁵,Guan Yu‐Juan⁶,Li Guo‐Jun⁷,Zeng Yi‐Lan⁸,Yang Jia‐Hong⁹,Chen Xin‐Yue¹⁰,Shang Jia¹¹,Li Jia‐Bin¹²,Gao Na¹,Gao Zhi‐Liang¹³⁴

Affiliation:

1. Department of Infectious Diseases the Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong China

2. Department of Infectious Diseases, Xiangya Hospital Central South University Changsha Hunan China

3. Guandong Key Laboratory of Liver Disease Research the Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong China

4. Key Laboratory of Tropical Disease Control (Sun Yat‐Sen University) Ministry of Education Guangzhou Guangdong China

5. Department of Gastroenterology the Second People's Hospital Yunnan Province Kunming Yunnan China

6. Department of Hepatology Guangzhou Eighth People's Hospital Guangzhou Guangdong China

7. Department of Hepatology Shenzhen Third People's Hospital Shenzhen Guangdong China

8. Department of Hepatology Chengdu Public Health Clinical Medical Center Chengdu Sichuan China

9. Department of Infectious Diseases Deyang People's Hospital Deyang Sichuan China

10. Department of Hepatology, Beijing You'an Hospital Capital Medical University Beijing China

11. Department of Infectious Diseases Henan Provincial People's Hospital Zhengzhou Henan China

12. Department of Infectious Diseases First Affiliated Hospital of Anhui Medical University Hefei Anhui China

Funder

National Major Science and Technology Projects of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13722

Reference36 articles.

1. Global Epidemiology of Hepatitis B Virus Infection

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

3. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance

4. Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naïve Patients With Chronic Hepatitis B

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Clinical Cure and off-treatment HBsAg Reversion in Patients with Chronic Hepatitis B receiving Peg-interferon-α-based Therapy;2023-12-20

2. Interferon stimulated immune profile changes in a humanized mouse model of HBV infection;Nature Communications;2023-11-15

3. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022);Journal of Clinical and Translational Hepatology;2023-08-15

4. Single-cell RNA sequencing reveals the immunoregulatory roles of PegIFN-α in patients with chronic hepatitis B;Hepatology;2023-06-27

5. Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue;Liver Research;2023-06